Investigation of single nucleotide polymorphisms and biological pathways associated with response to TNFα inhibitors in patients with rheumatoid arthritis
about
Anti-TNF treatment response in rheumatoid arthritis patients is associated with genetic variation in the NLRP3-inflammasomeVariation at FCGR2A and functionally related genes is associated with the response to anti-TNF therapy in rheumatoid arthritisGenetic Associations with Plasma B12, B6, and Folate Levels in an Ischemic Stroke Population from the Vitamin Intervention for Stroke Prevention (VISP) Trial.Systemic lupus erythematosus diagnostics in the 'omics' eraLack of validation of genetic variants associated with anti-tumor necrosis factor therapy response in rheumatoid arthritis: a genome-wide association study replication and meta-analysisGenome-wide association analysis of anti-TNF drug response in patients with rheumatoid arthritis.Insight in genome-wide association of metabolite quantitative traits by exome sequence analysesThe genetics of human autoimmune disease: A perspective on progress in the field and future directions.A longitudinal genome-wide association study of anti-tumor necrosis factor response among Japanese patients with rheumatoid arthritis.Previously reported PDE3A-SLCO1C1 genetic variant does not correlate with anti-TNF response in a large UK rheumatoid arthritis cohort.Pharmacogenomics in clinical practice and drug development.A genetic risk score composed of rheumatoid arthritis risk alleles, HLA-DRB1 haplotypes, and response to TNFi therapy - results from a Swedish cohort study.Pharmacogenetics of disease-modifying antirheumatic drugs in rheumatoid arthritis: towards personalized medicine.Pharmacogenomics of biological treatment in rheumatoid arthritis.Combining genetic and nongenetic biomarkers to realize the promise of pharmacogenomics for inflammatory diseases.Genetic and genomic markers of anti-TNF treatment response in rheumatoid arthritis.Systematic review and meta-analysis: pharmacogenetics of anti-TNF treatment response in rheumatoid arthritis.Emerging aspects of molecular biomarkers for diagnosis, prognosis and treatment response in rheumatoid arthritis.Genetic prediction of the effectiveness of biologics for psoriasis treatment.SFPQ, a multifunctional nuclear protein, regulates the transcription of PDE3ADoes a family history of RA influence the clinical presentation and treatment response in RA?Third Annual Open Meeting of the UK Pharmacogenomics and Stratified Medicine Network Conference.Right drug, right patient, right time: aspiration or future promise for biologics in rheumatoid arthritis?GWAS replication study confirms the association of PDE3A-SLCO1C1 with anti-TNF therapy response in rheumatoid arthritis.Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritis.A genome-wide association study identifies a new locus associated with the response to anti-TNF therapy in rheumatoid arthritis.Association of the PDE3A-SLCO1C1 locus with the response to anti-TNF agents in psoriasis.Validation study of genetic biomarkers of response to TNF inhibitors in rheumatoid arthritis.Pathway analysis to identify genetic variants associated with efficacy of adalimumab in rheumatoid arthritis.PDE3A-SLCO1C1locus is associated with response to anti-tumor necrosis factor therapy in psoriatic arthritis
P2860
Q28540052-C3E7BB4A-570A-413A-B10E-8CB55D1FD040Q28545783-422F9789-0A50-4F3A-A8E3-611151B0D8E8Q30411208-54E5BCFE-59E2-4745-BC62-6642D19E9BD4Q33644106-0CAABAF9-31D2-4E0B-9F31-69194BFAE048Q33766353-25D3035B-FB53-448A-9755-40A2C18A9F5BQ34216613-62A248E8-41BF-4A00-BD29-F23DAC1C747BQ34872431-E987C301-A911-41E3-A714-8D64780715CCQ36236745-908BF9D3-084D-4AF9-A2F1-64D0228AAC1EQ36477515-BA884890-7F8C-4AA5-8466-2FF46623CFF0Q37200651-9CF59599-E787-4D90-A614-AB732E41ABE0Q37284234-EA252A33-5E86-417C-A8D1-522C2123D915Q37470261-98697A80-5550-4EB7-82C9-670AC54515DFQ38084444-99E52A04-AA4C-4AA1-98D7-E5EE07EFE005Q38167894-50228B14-7392-4593-961F-8A0D7ED76B29Q38286234-79B4B6E3-3EA9-4144-8AB4-6D6D31B9E97DQ38529234-4CF01172-2597-4ED6-A95C-E93E015B8437Q38728689-7A5E4BCF-A814-440C-9060-CE5D7BDA214BQ38797638-1D2DF55B-A732-4A0A-A535-F6D005F798EBQ39808818-A75B8B74-2500-4293-9B1D-69CC0E3DA6E6Q41311328-A320EE9F-4AB4-47BA-A68F-69FD64373854Q41656399-D7C771AE-1872-4532-BE5D-7F87C6B3C512Q42629113-01DD50AF-AE6B-437F-B319-207A2AE226D0Q42633541-65CE19FE-D3E3-46C5-BA52-1EBCF23456B5Q46626086-13F860B4-81E2-47E9-AB6A-69A842618599Q48198050-29392C7A-EC89-402A-B35B-448B71D37E1DQ48198058-D0DA4405-8225-44A5-9D68-FE90C0BED375Q48252369-9E5EDA12-6464-4871-9F80-FA3D6CFEE031Q53820042-9F9199DB-40B9-411A-8306-8ABF44AFD6FDQ54595969-D58743AC-82BD-4989-B80E-4034AF03722DQ58529418-3BA55C18-48AD-440A-A13B-1BCE54A13DBF
P2860
Investigation of single nucleotide polymorphisms and biological pathways associated with response to TNFα inhibitors in patients with rheumatoid arthritis
description
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2012
@ast
im August 2012 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
wetenschappelijk artikel (gepubliceerd op 2012/08/01)
@nl
наукова стаття, опублікована в серпні 2012
@uk
مقالة علمية (نشرت في أغسطس 2012)
@ar
name
Investigation of single nucleo ...... ents with rheumatoid arthritis
@ast
Investigation of single nucleo ...... ents with rheumatoid arthritis
@en
type
label
Investigation of single nucleo ...... ents with rheumatoid arthritis
@ast
Investigation of single nucleo ...... ents with rheumatoid arthritis
@en
prefLabel
Investigation of single nucleo ...... ents with rheumatoid arthritis
@ast
Investigation of single nucleo ...... ents with rheumatoid arthritis
@en
P2093
P1476
Investigation of single nucleo ...... ents with rheumatoid arthritis
@en
P2093
Giuseppe Palermo
Julia S. Johansen
Laura Badi
Laurent Essioux
Mikkel Ostergaard
Ryma Benayed
Sophine B. Krintel
Søren Germer
P304
P356
10.1097/FPC.0B013E3283544043
P577
2012-08-01T00:00:00Z